Startup and Finance News

Startup and Finance News

Startup and Finance News

Startup

Jun 4, 2026

Beyond Antibodies: Clear2Cure Develops Therapeutics That Eliminate Disease-Causing Proteins

Targeted protein degradation is opening new possibilities in therapeutics. At Innovation for Health and Health~Holland Global Investor Forum 2026, Jord Stam, CEO of Clear2Cure, presented their novel Clearbodies® technology. Watch the video to discover how Clear2Cure is going beyond traditional antibodies to actively eliminate disease-causing molecules.

Startup

Jun 4, 2026

Beyond Antibodies: Clear2Cure Develops Therapeutics That Eliminate Disease-Causing Proteins

Targeted protein degradation is opening new possibilities in therapeutics. At Innovation for Health and Health~Holland Global Investor Forum 2026, Jord Stam, CEO of Clear2Cure, presented their novel Clearbodies® technology. Watch the video to discover how Clear2Cure is going beyond traditional antibodies to actively eliminate disease-causing molecules.

Startup

Jun 4, 2026

Beyond Antibodies: Clear2Cure Develops Therapeutics That Eliminate Disease-Causing Proteins

Targeted protein degradation is opening new possibilities in therapeutics. At Innovation for Health and Health~Holland Global Investor Forum 2026, Jord Stam, CEO of Clear2Cure, presented their novel Clearbodies® technology. Watch the video to discover how Clear2Cure is going beyond traditional antibodies to actively eliminate disease-causing molecules.

Startup

Van laboratorium naar longherstel

Startup

Van laboratorium naar longherstel

Startup

Van laboratorium naar longherstel

Startup

Adviezen van ervaren ondernemers versnellen valorisatie

Startup

Adviezen van ervaren ondernemers versnellen valorisatie

Startup

Adviezen van ervaren ondernemers versnellen valorisatie

Startup

Revividal - A new biomedical solution for treatment of obesity

Startup

Revividal - A new biomedical solution for treatment of obesity

Startup

Revividal - A new biomedical solution for treatment of obesity

Startup

Social Medicines drives systemic change—turning public research into sustained public access at scale

Startup

Social Medicines drives systemic change—turning public research into sustained public access at scale

Startup

Social Medicines drives systemic change—turning public research into sustained public access at scale

Startup

Daranamix wins Proefdiervrij Venture Challenge 2026

Startup

Daranamix wins Proefdiervrij Venture Challenge 2026

Startup

Daranamix wins Proefdiervrij Venture Challenge 2026

Startup

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

Startup

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

Startup

Myriagon is addressing unmet needs in chemotherapy-induced peripheral neuropathy treatment

Startup

Where you live should not determine whether your cancer is found in time

Startup

Where you live should not determine whether your cancer is found in time

Startup

Where you live should not determine whether your cancer is found in time

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

TIBEAY Biosciences raises EUR 35 million for a Phase 3b trial of Ronopterin in traumatic brain injury

Startup

Urimon is developing a multi-disease early warning system based on urinary microRNA profiling

Startup

Urimon is developing a multi-disease early warning system based on urinary microRNA profiling

Startup

Urimon is developing a multi-disease early warning system based on urinary microRNA profiling

Load More Startup News

Featured

MORE

Startup

Van laboratorium naar longherstel

Startup

Van laboratorium naar longherstel

Opinion

Pharming is 37 jaar oud en een unicorn

Opinion

Pharming is 37 jaar oud en een unicorn

Career

Werken bij MSD in Nederland: waar wetenschap en wereldwijde impact op het gebied van gezondheid samenkomen

Career

Werken bij MSD in Nederland: waar wetenschap en wereldwijde impact op het gebied van gezondheid samenkomen

Partnerships

Partnership results in full-service agency within Life Sciences

Partnerships

Partnership results in full-service agency within Life Sciences

Startup

Van laboratorium naar longherstel

Opinion

Pharming is 37 jaar oud en een unicorn

Career

Werken bij MSD in Nederland: waar wetenschap en wereldwijde impact op het gebied van gezondheid samenkomen

Advertisement

Advertisement